Contemporary In-Hospital Management Strategies for Acute Decompensated Heart Failure
Authors:
- Carlos E. SanchezCSCarlos E. Sanchez
- David R. RichardsDRDavid R. Richards
- 1 May 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 19 (3) , 122-129
Abstract
Acute decompensated heart failure (ADHF) is a common syndrome with diverse etiologies and precipitating factors, which is associated with significant morbidity and mortality. Tremendous resources are used in treating this syndrome, with few prospectively designed clinical trials to guide therapy. Patients suffering from ADHF are at increased risk for readmission to the hospital as well as an increased risk of death. Prompt identification and management of these patients can lead to shorter length of hospital stay, lower likelihood of readmission, and, perhaps, lower mortality. Initial treatment should target the relief of congestive symptoms. Intravenous loop diuretics are the mainstay of therapy, whereas ultrafiltration has emerged as a viable option in patients refractory to conventional treatment with diuretics. The safety and efficacy of nesiritide have been clarified in a recent large randomized trial, reassuring a favorable safety profile, but with modest improvement in short-term clinical outcomes. Thus, the preferred intravenous vasoactive medication has yet to be determined in large clinical trials, and positive inotropic agents should be reserved for patients with hemodynamic collapse. This article reviews the in-hospital assessment and management of ADHF.Keywords
This publication has 60 references indexed in Scilit:
- Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future AimsCirculation, 2010
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality InitiativeEuropean Heart Journal, 2009
- Early Vasoactive Drugs Improve Heart Failure OutcomesCongestive Heart Failure, 2009
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart FailureJACC, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Review of Current and Investigational Pharmacologic Agents for Acute Heart Failure SyndromesThe American Journal of Cardiology, 2007
- Short and long-term mortality with nesiritideAmerican Heart Journal, 2006
- Relationship between heart failure treatment and development of worsening renal function among hospitalized patientsAmerican Heart Journal, 2004
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Hormones and Hemodynamics in Heart FailureNew England Journal of Medicine, 1999